Consistent with this, in silico analysis of publicly available gene expression data-sets on breast cancer showed heterogeneous expression behaviour of RHBDF2 according to the intrinsic molecular subtypes and histopathological grading and staging (Canzoneri et al., 2014). This evidence concerns the gene RHBDF2 and breast carcinoma.